Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-07

FDA Approved: LORATADINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for loratadine from Lannett Company, expanding the availability of this generic antihistamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)

Snippet

SUPPL AP for LORATADINE (LORATADINE)